{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:00:01Z","timestamp":1791907201809,"version":"4.3.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T00:00:00Z","timestamp":1622160000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.eclinm.2021.100962","type":"journal-article","created":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T05:03:50Z","timestamp":1623992630000},"page":"100962","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":123,"special_numbering":"C","title":["Telmisartan for treatment of Covid-19 patients: An open multicenter randomized clinical trial"],"prefix":"10.1016","volume":"37","author":[{"given":"Mariano","family":"Duarte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Facundo","family":"Pelorosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana N.","family":"Nicolosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Victoria Salgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9ctor","family":"Vetulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anal\u00eda","family":"Aquieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Azzato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Coyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Davolos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio Fernandez","family":"Criado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosana","family":"Gregori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4959-1679","authenticated-orcid":false,"given":"Pedro","family":"Mastrodonato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda C.","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Sarquis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Wahlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4731-6099","authenticated-orcid":false,"given":"Rodolfo P.","family":"Rothlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.eclinm.2021.100962_bib0001","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1128\/JVI.00127-20","article-title":"Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus","volume":"94","author":"Wan","year":"2020","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.eclinm.2021.100962_bib0002","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/sj.jhh.1002101","article-title":"Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade","volume":"21","author":"Dandona","year":"2007","journal-title":"J Hum Hypertens"},{"issue":"1","key":"10.1016\/j.eclinm.2021.100962_bib0003","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-018-0968-4","article-title":"Angiotensin II-induced podocyte apoptosis is mediated by endoplasmic reticulum stress\/PKC-\u03b4\/p38 MAPK pathway activation and trough increased Na\u00a0+\u00a0\/H\u00a0+\u00a0exchanger isoform 1 activity","volume":"19","author":"Cardoso","year":"2018","journal-title":"BMC Nephrol"},{"issue":"2","key":"10.1016\/j.eclinm.2021.100962_bib0004","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41569-019-0244-8","article-title":"Counter-regulatory renin-angiotensin system in cardiovascular disease","volume":"17","author":"Paz Ocaranza","year":"2020","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"10.1016\/j.eclinm.2021.100962_bib0005","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","article-title":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury","volume":"63","author":"Liu","year":"2020","journal-title":"Sci China Life Sci"},{"key":"10.1016\/j.eclinm.2021.100962_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104370","article-title":"Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19","volume":"127","author":"Liu","year":"2020","journal-title":"J Clin Virol"},{"key":"10.1016\/j.eclinm.2021.100962_bib0007","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/jmv.25871","article-title":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early","volume":"927","author":"Tan","year":"2020","journal-title":"J Med Virol"},{"issue":"5","key":"10.1016\/j.eclinm.2021.100962_bib0008","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/ddr.21656","article-title":"Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics","volume":"81","author":"Gurwitz","year":"2020","journal-title":"Drug Dev Res"},{"issue":"5","key":"10.1016\/j.eclinm.2021.100962_bib0009","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.4049\/jimmunol.2000642","article-title":"SARS-CoV-2 as a factor to disbalance the renin\u2013angiotensin system: a suspect in the case of exacerbated IL-6 production","volume":"205","author":"Franco","year":"2020","journal-title":"J Immunol"},{"key":"10.1016\/j.eclinm.2021.100962_bib0010","doi-asserted-by":"crossref","unstructured":"Minato T., Hoshizaki, M., Yamaguchi, T., An, J., Niiyama, M., Nirasawa, S., Asaka, M.N., Fuk-Woo Chan, J., Imai, M., Takahashi, S., Utsumi, D., Kwok-Man Poon, V., Yasuhara, A., Chung-Sing Chan, C., Motoyama, S., Nagata, S., Penninger, J.M., Kamada, H., Yuen, K., Kawaoka, Y., Yasutomi, Y., Imai, Y., Kuba K. ACE2-like carboxypeptidase B38-CAP protects from SARS-CoV-2-induced lung injury. DOI 1021203\/rs3rs-124634\/v1. 2020.","DOI":"10.21203\/rs.3.rs-124634\/v1"},{"issue":"15","key":"10.1016\/j.eclinm.2021.100962_bib0011","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/cid\/ciaa272","article-title":"Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China","volume":"71","author":"Wang","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"18","key":"10.1016\/j.eclinm.2021.100962_bib0012","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1056\/NEJM200005043421806","article-title":"The acute respiratory distress syndrome","volume":"342","author":"Ware","year":"2000","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.eclinm.2021.100962_bib0013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009128","article-title":"SARS-CoV-2 spike protein promotes IL-6 trans-signaling by activation of angiotensin II receptor signaling in epithelial cells","volume":"16","author":"Patra","year":"2020","journal-title":"PLoS Pathog"},{"issue":"7","key":"10.1016\/j.eclinm.2021.100962_bib0014","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9072315","article-title":"The plasmatic aldosterone and C-reactive protein levels, and the severity of Covid-19: the dyhor-19 Study","volume":"9","author":"Villard","year":"2020","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.eclinm.2021.100962_bib0015","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jinf.2020.05.052","article-title":"Estimation of renin-angiotensin-aldosterone-system (RAAS)-inhibitor effect on COVID-19 outcome: a meta-analysis","volume":"81","author":"Pirola","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.eclinm.2021.100962_bib0016","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1161\/HYPERTENSIONAHA.120.15572","article-title":"Decreased mortality of COVID-19 with renin-angiotensin-aldosterone system inhibitors therapy in patients with hypertension:a meta-analysis","volume":"76","author":"Guo","year":"2020","journal-title":"Hypertension"},{"issue":"8","key":"10.1016\/j.eclinm.2021.100962_bib0017","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1093\/infdis\/jiaa447","article-title":"Continued in-hospital angiotensin-converting enzyme inhibitor and angiotensin ii receptor blocker use in hypertensive COVID-19 patients is associated with positive clinical outcome","volume":"222","author":"Lam","year":"2020","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.eclinm.2021.100962_bib0018","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41421-020-00221-6","article-title":"Antihypertensive drugs are associated with reduced fatal outcomes and improved clinical characteristics in elderly COVID-19 patients","volume":"6","author":"Yan","year":"2020","journal-title":"Cell Discov"},{"issue":"1","key":"10.1016\/j.eclinm.2021.100962_bib0019","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2016877118","article-title":"A data-driven approach to identify risk profiles and protective drugs in COVID-19","volume":"118","author":"Cipp\u00e0","year":"2021","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"10.1016\/j.eclinm.2021.100962_bib0020","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.3594","article-title":"Association between renin-angiotensin-aldosterone system inhibitors and clinical outcomes in patients with COVID-19: a systematic review and meta-analysis","volume":"4","author":"Baral","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"7","key":"10.1016\/j.eclinm.2021.100962_bib0021","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/ddr.21679","article-title":"Telmisartan as tentative angiotensin receptor blocker therapeutic for COVID-19","volume":"81","author":"Rothlin","year":"2020","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.eclinm.2021.100962_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.603736","article-title":"Angiotensin receptor blockers for COVID-19: pathophysiological and pharmacological considerations about ongoing and future prospective clinical trials","volume":"12","author":"Rothlin","year":"2021","journal-title":"Front Pharmacol"},{"issue":"10","key":"10.1016\/j.eclinm.2021.100962_bib0023","doi-asserted-by":"crossref","first-page":"i10","DOI":"10.18637\/jss.v054.i10","article-title":"GLIMMPSE: online power computation for linear models with and without a baseline covariate","volume":"54","author":"Kreidler","year":"2013","journal-title":"J Stat Softw"},{"issue":"6","key":"10.1016\/j.eclinm.2021.100962_bib0024","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/pst.1964","article-title":"Empirical evaluation of the implementation of the EMA guideline on missing data in confirmatory clinical trials: specification of mixed models for longitudinal data in study protocols","volume":"18","author":"H\u00e4ckl","year":"2019","journal-title":"Pharm Stat"},{"issue":"2","key":"10.1016\/j.eclinm.2021.100962_bib0025","first-page":"65","article-title":"A Simple Sequentially Rejective Multiple Test Procedure","volume":"6","author":"Holm","year":"1979","journal-title":"Scand J Stat"},{"key":"10.1016\/j.eclinm.2021.100962_bib0026","doi-asserted-by":"crossref","unstructured":"Duarte M., Pelorosso F.G., Nicolosi L., Salgado M.V., Vetulli H., Aquieri A., et\u00a0al. Telmisartan for treatment of Covid-19 patients: an open randomized clinical trial. Preliminary report. medRxiv. 2020:2020.08.04.20167205-2020.08.04.","DOI":"10.1101\/2020.08.04.20167205"},{"issue":"1","key":"10.1016\/j.eclinm.2021.100962_bib0027","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12941-020-00362-2","article-title":"Plasma CRP level is positively associated with the severity of COVID-19","volume":"19","author":"Chen","year":"2020","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.eclinm.2021.100962_bib0028","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1124\/pr.112.007278","article-title":"A systematic comparison of the properties of clinically used angiotensin II type 1 receptor antagonists","volume":"65","author":"Michel","year":"2013","journal-title":"Pharmacol Rev"},{"issue":"1","key":"10.1016\/j.eclinm.2021.100962_bib0029","first-page":"41","article-title":"Telmisartan has the strongest binding affinity to angiotensin II type 1 receptor: comparison with other angiotensin II type 1 receptor blockers","volume":"25","author":"Kakuta","year":"2005","journal-title":"Int J Clin Pharmacol Res"},{"issue":"4","key":"10.1016\/j.eclinm.2021.100962_bib0030","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/JLB.3MR0118-034R","article-title":"PPAR-\u03b3 in innate and adaptive lung immunity","volume":"104","author":"Nobs","year":"2018","journal-title":"J Leukoc Biol"},{"issue":"1","key":"10.1016\/j.eclinm.2021.100962_bib0031","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10571-017-0554-5","article-title":"Roles of peroxisome proliferator-activated receptor gamma on brain and peripheral inflammation","volume":"38","author":"Villapol","year":"2018","journal-title":"Cell Mol Neurobiol"},{"issue":"1","key":"10.1016\/j.eclinm.2021.100962_bib0032","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1080\/08038020802144383","article-title":"The safety profile of telmisartan as monotherapy or combined with hydrochlorothiazide: a retrospective analysis of 50 studies","volume":"17","author":"Schumacher","year":"2008","journal-title":"Blood Press"},{"issue":"4","key":"10.1016\/j.eclinm.2021.100962_bib0033","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/147323000002800401","article-title":"Pharmacokinetics of orally and intravenously administered telmisartan in healthy young and elderly volunteers and in hypertensive patients","volume":"28","author":"Stangier","year":"2000","journal-title":"J Int Med Res"},{"issue":"6","key":"10.1016\/j.eclinm.2021.100962_bib0034","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1053\/j.ajkd.2005.08.034","article-title":"Long-term renoprotective effects of standard versus high doses of telmisartan in hypertensive nondiabetic nephropathies","volume":"46","author":"Aranda","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.eclinm.2021.100962_bib0035","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0149-2918(01)80072-2","article-title":"Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial","volume":"23","author":"McGill","year":"2001","journal-title":"Clin Ther"},{"issue":"4","key":"10.1016\/j.eclinm.2021.100962_bib0036","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.amjhyper.2006.10.002","article-title":"Effect of telmisartan\u2013amlodipine combination at different doses on urinary albumin excretion in hypertensive diabetic patients with microalbuminuria","volume":"20","author":"Fogari","year":"2007","journal-title":"Am J Hypertens"},{"issue":"1","key":"10.1016\/j.eclinm.2021.100962_bib0037","doi-asserted-by":"crossref","first-page":"6317","DOI":"10.1038\/s41467-020-19741-6","article-title":"Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission","volume":"11","author":"Peckham","year":"2020","journal-title":"Nat Commun"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258953702100242X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258953702100242X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T19:05:15Z","timestamp":1762887915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258953702100242X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":37,"alternative-id":["S258953702100242X"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2021.100962","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.08.04.20167205","asserted-by":"object"}]},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Telmisartan for treatment of Covid-19 patients: An open multicenter randomized clinical trial","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2021.100962","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100962"}}